Anti-Cancer Drugs

Anti-Cancer Drug Discovery and Development

Evolution of drugs to selectively interfere with and slow down tumour growth has now entered a new and exciting era of the target orientated approach. Drugs are now being evolved against specific proteins included in cancer cell growth that have been uncovered over the last 10 years or so. The drug discovery operation is still a mixture of random screening and rational drug design. Relationships between academia and industry in drug discovery and development have continued to change over time as a result of technical and financial challenges and, most importantly, to the neutral of translating effective scientific discoveries into clinical opportunities.